NCT02260765View on ClinicalTrials.gov

Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Depression
Interventions
DEVICE

dTMS

The Brainsway H-Coil TMS device is intended for the treatment of depressive episodes in patients suffering from Major Depressive Disorder (MDD). The device technology is based on the application of deep TMS by means of repetitive pulse trains at a determined frequency

Trial Locations (1)

90015

Healthcare Partners, Los Angeles

Sponsors

Lead Sponsor

Brainsway
All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT02260765 - Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual | Biotech Hunter | Biotech Hunter